Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract

Active
HT942626RE002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Health Agency Contracting Activity is preparing to issue an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity contract vehicle, which supports military medical research and development services across four distinct market segments: medical research and development support, general research and development support, regulatory processes for human and animal research, and translational science services for moving innovations from laboratory to clinical practice. This on-ramp opportunity is exclusively set-aside for small businesses certified under the Small Business Administration’s 8(a) Program, with the aim of expanding the pool of qualified contractors while maintaining alignment with the existing unrestricted contract vehicle. The OMNIBUS IV IDIQ has a cumulative ceiling of $10 billion and has already generated over $600 million in task order awards across 51 task orders since its base period began in 2022, with the majority of activity occurring in fiscal years 2024 through 2026. Task orders are competitively awarded, including set-asides for 8(a) participants, and may be issued by various DoD entities including DHACA, the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. The upcoming solicitation, expected to be posted on SAM.gov in late February 2026, follows a delay to align with the February 2026 implementation of the FAR Overhaul, which significantly impacts how small business status is handled under unrestricted IDIQ contracts. Under the new rules, contractors do not need to recertify their small business status at the task order level when bidding on 8(a)-set-aside work, as they may rely on their original IDIQ-level size and status representation—even if they have graduated from the 8(a) Program or grown beyond small business size thresholds. However, contractors must still recertify their status at the IDIQ level within 60 to 120 days prior to the end of the fifth contract year, in compliance with FAR 19.301-2(b)(1)(iii)(A). Proposals must be submitted via the PIEE Solicitation module using a SAM.gov-registered account, and while the initial pre-solicitation notice provides the framework and intent, detailed evaluation criteria, submission instructions, and contract clauses will be formally outlined in the forthcoming RFP. All awards under this on-ramp will be made to small business 8(a) participants, and the government anticipates issuing multiple new contracts

General Info

DHACA issues SBA 8(a)-set-aside RFP for military medical R&D under $10B OMNIBUS IV IDIQ contract.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD

Set-Aside

8A

Documents

(1)

HT942626R0002 Omnibus IV Pre-solicitation Notice Amendment 01

DOCX4 pagespresolicitation-amendment

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

5 updates
PhasePresolicitation
Posted

Presolicitation

Amendment 1

Contract was updated

Amendment 2

Contract was updated

Amendment 3

Contract was updated

Amendment 4

Contract was updated

Amendment 5

Contract was updated

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts1 person available
OfficeFORT DETRICK, MD, 21702, USA
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressFORT DETRICK, MD, 21702, USA
Contacts

Full Description

Show more
Amendment 0005 to this pre-solicitation notice is to extend the anticipated posting timeframe of the solicitation to late September 2026. Additional time is needed to implement the recent guidance pertaining to the FAR Overhaul. This is a pre-solicitation notice to synopsize the intention of the Defense Health Agency Contracting Activity (DHACA) to issue a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle covering military medical research and development services. The eventual RFP will be set-aside for small businesses certified under the Small Business Administration 8(a) Program. The Government anticipates making multiple new awards under this on-ramp, and all new awards will align with the existing unrestricted contract vehicle. This notice is not a request for proposals and does not commit the Government to any contractual agreement. The OMNIBUS IV contract vehicle was awarded under full and open competition with a base ordering period of 20 June 2022 through 19 June 2027 and an Option Ordering Period of 20 June 2027 19 June 2032. Task orders may be competed under fair opportunity (providing all Contract Holders within a Market Segment the opportunity to submit a proposal) or an exception to fair opportunity (such as set-asides for small businesses or applicable small business socioeconomic categories). The cumulative ceiling of this unrestricted IDIQ contract vehicle is $10 billion. To date, the accumulated awarded task order value (including future unexercised option periods) is over $630 million across 55 task orders. Task Orders have been issued by a growing number of end users including DHACA, the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. When excluding the task orders simply providing a minimum guarantee to the existing Contract Holders, 55 task orders have been issued off this contract vehicle with 8 task orders being set aside for the 8(a) Program and 11 task orders being awarded to an 8(a) Participant. 36 task orders have been awarded so far to small businesses under this contract vehicle. Of the 55 task orders, 94.5% were awarded during the Government Fiscal Years 2024 - 2026, and the amount of competitive task orders has grown each fiscal year. Please see attachments for further details.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.
W6QK Acc-Apg

POSTED

about 13 hours ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells
Solicitation # NIH-NOI-PCA-NIA-01590
The National Institute on Aging (NIA), under the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), has issued a Notice of Intent to Sole Source for the validation and optimization of ONE-STEP tagging in human induced pluripotent stem cells (iPSCs). This acquisition aims to support the iPSC Neurodegenerative Disease Initiative (iNDI) and the Center of Alzheimer’s Disease and Related Dementias (CARD) by generating functionally engineered iPSC lines for research into Alzheimer’s disease and related dementias. The project involves high-activity guide identification, Bxb1 mRNA and cargo plasmid delivery optimization, and the generation of ADRD variant, MAPT 4R, and wild-type process-control clones. All deliverables must be repository-ready, meeting strict quality control standards including long-read sequencing, karyotype analysis, and SNP arrays to ensure scientific continuity and data integrity. The government intends to award this contract to The Jackson Laboratory, citing them as the only responsible source capable of meeting the requirements under FAR 6.302-1 and FAR 13.501(a). This determination is based on the laboratory's unique continuity with the existing iNDI program, established workflows for specific background lines, and proven success in large-scale CRISPR/Cas9 engineering. The total estimated contract value is 3,353,115.00 dollars, covering a base year from September 1, 2026, to August 31, 2027, and an option year extending to August 31, 2028. While this is a sole-source intent, the government will consider capability statements from other sources submitted by August 21, 2026, to determine if adequate competition exists.
National Institutes Of Health Olao

POSTED

3 days ago

DEADLINE

in 1 day
View Details

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 325120
New
Federal
Deliveries of Bulk Liquid Oxygen for the Landstuhl Regional Medical Center (LRMC), Germany
Solicitation # HT940626QE057
The Defense Health Agency is soliciting a single-award, Firm-Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the supply and delivery of medicinal bulk liquid oxygen to the Landstuhl Regional Medical Center (LRMC) in Germany. The contract spans a base year from October 1, 2026, to September 30, 2027, with three additional one-year ordering periods extending through September 30, 2030. The scope includes the annual supply of 50,000 cubic meters of medical-grade liquid oxygen with a minimum purity of 99.5%, the rental and comprehensive maintenance of one vertical bulk storage tank, and telemetry monitoring. Deliveries are FOB Destination, featuring automatic refills at 20% capacity and a mandatory 4-hour emergency response time. The contractor is responsible for all periodic TUV safety testing and certifications in accordance with German regulations and must ensure all delivery personnel are fluent in English. Technical evaluation is based on a pass/fail basis regarding purity standards and compliance with USP, DAB, or EUAB monographs, while the final award is determined by the most advantageous quote considering price and other factors. Invoicing must be processed through Wide Area WorkFlow (WAWF), and contractors must maintain active SAM.gov registration. All quotes, including a completed SF 1449, pricing schedule, and Certificate of Analysis, must be submitted electronically by August 24, 2026, at 16:00 CET.
Industrial Gas Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 541513
New
Federal
Program Executive Office Defense Healthcare Management Systems’ (PEO DHMS) Enterprise Software Services (ESS) Next
Solicitation # HT003826SC003
The Defense Health Agency Contracting Activity is issuing a Commercial Solutions Opening for Enterprise Support Services Next under solicitation number HT003826SC003, aimed at securing advanced software services to support the Program Executive Office for Defense Healthcare Management Systems. This solicitation remains open until August 20, 2026, at 3:00 PM CST, with the possibility of updates prior to closure. Respondents may submit proprietary or sensitive information, but must clearly mark such material to ensure it is safeguarded from unauthorized disclosure, limited to government personnel unless explicit permission is granted for support contractors to access it. Two designated organizations, Boston Consulting Group and Andrew Morgan, LLC, are contractually bound by organizational conflict of interest and confidentiality clauses to protect submitted proprietary data. Submission to this CSO automatically grants the government authority to involve non-government advisors in evaluating proposals; companies with concerns about third-party access to sensitive information are urged to contact the listed point of contacts before submitting. The contract is administered by the Department of Defense through the Defense Health Agency, with the primary office located in Rosslyn, Virginia, and no set-aside provisions apply. Primary and secondary points of contact are Krystal Mason and J R Oliver, respectively, for inquiries regarding the solicitation.
Computer Facilities Management Services

POSTED

about 13 hours ago

DEADLINE

in about 20 hours
View Details